Tennessee Zantac OTC Lawsuit Lawyer
If you or someone you love took Zantac or another ranitidine medication, you could be eligible to file a claim against the drug manufacturer. This dangerous drug has been recalled from the market due to the presence of a contaminant known as N-Nitrosodimethylamine (NDMA). This contaminant has been linked to various types of cancer diagnoses. Accordingly, it is critical to seek advice from an attorney if you have been taking Zantac and have received a cancer diagnosis. One of the aggressive Tennessee Zantac OTC lawyers at our firm can begin working on your claim today.
What is a Zantac OTC Lawsuit?
One of the major types of ranitidine medications that was recalled due to cancer risks is Zantac—both prescription and over-the-counter (OTC) versions of the drug. Zantac OTC lawsuits are legal claims seeking financial compensation that are filed by patients who took over-the-counter Zantac and developed cancer. Patients have filed claims against Sanofi, the drug maker of Zantac, and other manufacturers of ranitidine.
Zantac and other ranitidine medications are part of a group of drugs that are histamine-2 blockers. These medicines are designed to reduce the amount of acid produced by a person’s stomach. As such, Zantac OTC, prescription Zantac, and other generic ranitidine drugs are used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to prevent and treat ulcers.
How is NDMA Dangerous for Zantac OTC Patients?
According to the U.S. Food and Drug Administration (FDA), NDMA has been found in a variety of ranitidine products, including Zantac OTC, and the presence of this contaminant “increases over time and when stored at higher room temperatures.” When patients use Zantac or other ranitidine products that contain NDMA, those consumers can be exposed to “unacceptable levels” of the contaminant. In April 2020, the FDA issued a press release making clear that it had recalled all ranitidine drugs from the U.S. marketplace to prevent further consumer exposure to NDMA.
The FDA explains that NDMA is classified as a “probable human carcinogen,” which means that it is a “substance that could cause cancer.” Zantac OTC and other ranitidine products have been linked to many different types of cancers, including but not limited to the following:
- Bladder cancer;
- Blood cancers;
- Breast cancer;
- Colon cancer;
- Gastric cancer;
- Liver cancer;
- Lung cancer;
- Ovarian cancer;
- Pancreatic cancer;
- Prostate cancer;
- Renal cancer;
- Stomach cancer;
- Thyroid cancer; and
- Uterine cancer.
How Much Time Do I Have to File a Zantac OTC Lawsuit?
Patients in Tennessee who plan to file a product liability claim against Sanofi need to be aware of the statute of limitations. Under Tennessee law, most product liability lawsuits must be filed within one year from the date of the injury. An experienced Tennessee product liability attorney at our firm can help you determine the date by which you must file a claim.
Contact a Dangerous Drug Lawyer in Tennessee
The sooner you get in touch with one of the experienced Tennessee dangerous drug attorneys at our firm, the sooner we can begin working on your Zantac OTC lawsuit. Contact Fox, Farley, Willis & Burnette for more information about filing a claim for financial compensation.